<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMC Pediatr</journal-id>
<journal-id journal-id-type="iso-abbrev">BMC Pediatr</journal-id>
<journal-title-group>
<journal-title>BMC Pediatrics</journal-title>
</journal-title-group>
<issn pub-type="epub">1471-2431</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32070310</article-id>
<article-id pub-id-type="pmc">7027286</article-id>
<article-id pub-id-type="publisher-id">1976</article-id>
<article-id pub-id-type="doi">10.1186/s12887-020-1976-7</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Dynamics of toxigenic <italic>Clostridium perfringens</italic> colonisation in a cohort of prematurely born neonatal infants</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3166-872X</contrib-id>
<name>
<surname>Shaw</surname>
<given-names>Alexander G.</given-names>
</name>
<address>
<email>a.shaw@imperial.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Cornwell</surname>
<given-names>Emma</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sim</surname>
<given-names>Kathleen</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thrower</surname>
<given-names>Hannah</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scott</surname>
<given-names>Hannah</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brown</surname>
<given-names>Joseph C. S.</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dixon</surname>
<given-names>Ronald A.</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kroll</surname>
<given-names>J. Simon</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2113 8111</institution-id><institution-id institution-id-type="GRID">grid.7445.2</institution-id><institution>Department of Infectious Disease Epidemiology, </institution><institution>Imperial College London, </institution></institution-wrap>London, UK </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2113 8111</institution-id><institution-id institution-id-type="GRID">grid.7445.2</institution-id><institution>Department of Medicine, Section of Paediatrics, </institution><institution>Imperial College London, </institution></institution-wrap>London, UK </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0420 4262</institution-id><institution-id institution-id-type="GRID">grid.36511.30</institution-id><institution>School of Life Sciences, </institution><institution>University of Lincoln, </institution></institution-wrap>Lincoln, UK </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>18</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>18</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>20</volume>
<elocation-id>75</elocation-id>
<history>
<date date-type="received">
<day>1</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>2</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2020</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1"><italic>Clostridium perfringens</italic> forms part of the human gut microbiota and has been associated with life-threatening necrotising enterocolitis (NEC) in premature infants. Whether specific toxigenic strains are responsible is unknown, as is the extent of diversity of strains in healthy premature babies. We investigated the <italic>C. perfringens</italic> carrier status of premature infants in the neonatal intensive care unit, factors influence this status, and the toxic potential of the strains.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2"><italic>C. perfringens</italic> was isolated by culture from faecal samples from 333 infants and their toxin gene profiles analysed by PCR. A survival analysis was used to identify factors affecting probability of carriage. Competitive growth experiments were used to explore the results of the survival analysis.</p>
</sec>
<sec>
<title>Results</title>
<p id="Par3">29.4% of infants were colonized with <italic>C. perfringens</italic> before they left hospital. Three factors were inversely associated with probability of carriage: increased duration of maternal milk feeds, CPAP oxygen treatment and antibiotic treatment. <italic>C. perfringens</italic> grew poorly in breast milk and was significantly outperformed by <italic>Bifidobacterium infantis</italic>, whether grown together or separately. Toxin gene screening revealed that infants carried isolates positive for collagenase, perfringolysin O, beta 2, beta, <italic>becA/B</italic>, <italic>netB</italic> and enterotoxin toxin genes, yet none were observed to be associated with the development of NEC.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par4">Approximately a third of preterm infants are colonised 3 weeks after birth with toxin gene-carrying <italic>C. perfringens</italic>. We speculate that increased maternal breast milk, oxygen and antibiotic treatment creates an environment in the gut hostile to growth of <italic>C. perfringens</italic>. Whilst potentially toxigenic <italic>C. perfringens</italic> isolates were frequent, no toxin type was associated with NEC.</p>
</sec>
<sec>
<title>Trial registration</title>
<p id="Par5"><ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov">clinicaltrials.gov</ext-link>
<ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT01102738">NCT01102738</ext-link>, registered 13th April 2010.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>
<italic>Clostridium perfringens</italic>
</kwd>
<kwd>Breast milk</kwd>
<kwd>Toxins</kwd>
<kwd>Necrotising enterocolitis</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>The Winnicott Foundation</institution>
</funding-source>
<award-id>P26859</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Micropathology Ltd</institution>
</funding-source>
<award-id>P25076</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006041</institution-id>
<institution>Innovate UK</institution>
</institution-wrap>
</funding-source>
<award-id>KTP9440</award-id>
<principal-award-recipient>
<name>
<surname>Dixon</surname>
<given-names>Ronald A.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>National Institute for Health Research (NIHR) Biomedical Research Centre</institution>
</funding-source>
<award-id>P35969</award-id>
<principal-award-recipient>
<name>
<surname>Sim</surname>
<given-names>Kathleen</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par23"><italic>Clostridium perfringens</italic> is an archetypal pathosymbiont, forming part of the gut commensal microbiota in humans and animals, but also capable of producing devastating disease by way of its toxin arsenal. This anaerobic, Gram-positive spore-former is the leading cause of traumatic gas gangrene in humans [<xref ref-type="bibr" rid="CR1">1</xref>] and one of the most common causes of food poisoning, responsible for an estimated 1 million cases in the US each year [<xref ref-type="bibr" rid="CR2">2</xref>]. <italic>C. perfringens</italic> has been linked to necrotizing enterocolitis (NEC) – an inflammatory bowel disease with high mortality – in preterm neonates [<xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR7">7</xref>]. This condition has several predisposing factors; an immature gut, the presence of bacteria and potentially hypoxia and ischemia around the site of pathology [<xref ref-type="bibr" rid="CR3">3</xref>]. A single causative organism has however remained elusive, with studies having found associations with other components of the gut microbiota such as the Enterobacteriaceae [<xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR9">9</xref>]. The toxic potential of <italic>C. perfringens</italic> in relation to the genesis of NEC remains intriguing. A role has also been proposed for <italic>Clostridium</italic> spp. in infant atopy and allergic sensitisation [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>] and autism [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>].</p>
<p id="Par24">Previous studies investigating clostridial carriage in apparently healthy premature neonates have often involved small sample sizes, [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>] or reflected the opportunity to study control groups recruited for studies of topics such as the effect of different feeding or probiotic regimes [<xref ref-type="bibr" rid="CR16">16</xref>]. We have recruited a large cohort of well-characterised premature neonates who were treated according to standard care protocols and provided faecal samples from birth until their departure from hospital. The microbiota profiles of these neonates were previously characterised by next-generation sequencing which identified significantly higher levels of <italic>C. perfringens</italic> in a subset of infants who were diagnosed with NEC compared to controls [<xref ref-type="bibr" rid="CR7">7</xref>]. In the present current study, our first aim has been to use a culture-dependent approach to build up a collection of neonatal <italic>C. perfringens</italic> isolates and establish colonisation dynamics in the cohort. We have gone on to relate this to perinatal factors which we hypothesise will influence rates of carriage.</p>
<p id="Par25">We have investigated the toxin gene carriage rates in these neonatal <italic>C. perfringens</italic> isolates. <italic>C. perfringens</italic> strains encode a formidable arsenal of more than 20 toxins [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]- many with cytotoxic effects - including the well-characterised alpha toxin, beta toxin, and the <italic>C. perfringens</italic> enterotoxin (CPE, encoded by the <italic>cpe</italic> gene), which are respectively implicated in the human diseases gas gangrene, necrotic enteritis (Pigbel) and food poisoning (see Supplementary Material <xref ref-type="media" rid="MOESM1">1</xref>). Previous studies have shown that toxigenic <italic>C. perfringens</italic> strains are present in healthy adult populations (see Supplementary Material <xref ref-type="media" rid="MOESM1">1</xref>), but there is a lack of data for neonatal populations and also for toxins other than the 4 major and 2 minor toxins that make up standard multiplex PCR screens for assigning toxin type and investigating cases of food poisoning [<xref ref-type="bibr" rid="CR19">19</xref>]. We here report the result of screening for the presence of 11 toxin genes; <italic>cpa</italic>, <italic>cpb</italic>, <italic>etx</italic>, <italic>itx</italic>, <italic>cpe</italic>, <italic>cpb2</italic>, <italic>netB</italic>, <italic>becA</italic>, <italic>becB</italic>, <italic>pfoA</italic> and <italic>colA</italic> (see Supplementary Material <xref ref-type="media" rid="MOESM1">1</xref> for characterisations) in our neonatal isolates, seeking possible associations with NEC and establishing the normal clostridial toxin gene carriage rates in premature infants during their stay on the neonatal intensive care unit.</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<sec id="Sec3">
<title>Study population</title>
<p id="Par26">Infants born &lt; 32 weeks gestation admitted to an Imperial College Healthcare National Health Service Trust neonatal intensive care unit (St Mary’s Hospital, Queens Charlotte’s and Chelsea Hospital) between January 2010 and December 2011 were eligible for inclusion in our ecological study “Defining the Intestinal Microbiota in Premature Infants” (The Neonatal Microbiota (NeoM) Study). Both hospitals have identical antibiotic and feeding protocols and staff members rotate between sites. Detailed daily clinical records were collected for all participants. Of the 369 babies recruited, 333 provided faecal samples for analysis in the present study (a total of 1399 samples).</p>
</sec>
<sec id="Sec4">
<title>Sample collection</title>
<p id="Par27">We collected every faecal sample produced by participants between admission and discharge. Samples were collected by nursing staff from diapers using a sterile spatula and placed in a sterile DNAase-, RNAase-free Eppendorf tube. These were stored at − 20 °C within 2 h of collection and were transferred to − 80 °C storage within 5 days. Approximately one sample per week was selected for culture.</p>
</sec>
<sec id="Sec5">
<title>Clostridium culture protocol</title>
<p id="Par28">Selective culture for clostridia species was performed using an ethanol shock methodology to eliminate non-spore forming organisms [<xref ref-type="bibr" rid="CR20">20</xref>]. 25 mg of faeces was added to 500 μl of cooked meat broth (Oxoid) and 500 μl of 100% ethanol and vortexed for 10 sec before incubating for 30 min at room temperature. A sterile loop was dipped in the supernatant and streaked onto a fastidious anaerobic agar plate supplemented with 0.1% sodium taurocholate hydrate (Sigma) and 5% defibrinated sheep blood (Oxoid). Plates were incubated anaerobically at 37 °C for 48 h in an Oxoid 2.5 l AnaeroJar plus AnaeroGen sachet. Resulting colonies were examined and for each morphologically distinct isolate, four colonies were subcultured by streaking onto Colombia agar with sheep blood (Oxoid) plates which were incubated anaerobically at 37 °C for 48 h. Single colonies were used for identification to the species level by matrix-assisted laser desorption/ ionization–time of flight (MALDI-TOF) using a Bruker Microflex LT (Bruker Daltonics), and the remainder of the subculture stored in 70% brain heart infusion (BHI) broth (Oxoid), 30% glycerol (Sigma) at − 80 °C.</p>
</sec>
<sec id="Sec6">
<title>Toxin typing of <italic>Clostridium perfringens</italic> by polymerase chain reaction (PCR)</title>
<p id="Par29">PCR reactions were performed to detect <italic>cpa</italic>, <italic>cpb</italic>, <italic>iA</italic>, <italic>etx</italic>, <italic>cpe</italic> and <italic>cpb2</italic> (multiplex PCR), <italic>becA</italic> and <italic>becB</italic> (duplex PCR) and <italic>netB, pfoA</italic>, and <italic>colA</italic> (single PCR) and visualised by gel electrophoresis. For details see Supplementary Material <xref ref-type="media" rid="MOESM2">2</xref>.</p>
</sec>
<sec id="Sec7">
<title>Breast milk growth competition experiment</title>
<p id="Par30"><italic>Bifidobacterium infantis</italic> (NCIMB 702255 – isolated from infant intestine), and <italic>Clostridium perfringens</italic> isolated from the faeces of an infant enrolled in our study were cultured either in Wilkins-Chalgren broth (WCB) (Oxoid) supplemented with 5 g/l soya peptone (Oxoid), or human breast milk. Three donors gave breast milk on three occasions, for which informed consent was obtained and standardised expression protocols used. Breast milk was expressed on average 16 h before each experiment, was kept refrigerated at all times, and had a commensal microbial load (anaerobic) below the NICE-recommended limit (10<sup>5</sup> colony forming units (CFU)/ml total viable organisms or 10<sup>4</sup> CFU/ml Enterobacteriaceae or <italic>Staphylococcus aureus</italic>) [<xref ref-type="bibr" rid="CR21">21</xref>], which was calculated by plating directly onto Colombia agar with sheep blood (Oxoid) and incubating for 48 h at 37 °C, followed by species identification using MALDI-TOF. The majority of organisms found in this manner were <italic>Staphylococcus</italic> and <italic>Actinomyces</italic> spps. <italic>Staphylococcus</italic> spp. were grown in every breast milk sample, whilst <italic>Actinomyces</italic> spp. were found in the milk of only one mother (see Supplementary Material <xref ref-type="media" rid="MOESM3">3</xref>). For bacterial counts, <italic>C. perfringens</italic> was grown on Tryptose Sulphite Cycloserine (TSC) agar plates (Oxoid) [<xref ref-type="bibr" rid="CR22">22</xref>], and incubated for 24 h at 37 °C, and <italic>B. infantis</italic> on Bifidus Selective Medium (BSM) agar plates (Sigma) incubated for 48 h at 37 °C. All cultivation was performed under anaerobic conditions using an Oxoid 2.5 l AnaeroJar plus AnaeroGen sachet in a shaking or static 37 °C incubator.</p>
<p id="Par31">Bacteria were grown in WCB to an optical density of approximately 0.7, and approximately 1 × 10<sup>4</sup> colony forming units (CFUs) added to 2.5 ml of breast milk or 2.5 ml of WCB in 15 ml bioreactor tubes (TTP). Media were inoculated with <italic>C. perfringens</italic> or <italic>B. infantis</italic> (monoculture), or both (co-culture). <italic>C. perfringens</italic> and <italic>B. infantis</italic> were enumerated after 20 h incubation by plating dilutions in triplicate onto TSC agar and BSM agar respectively. Breast milk from three different donors was used and experiments carried out in triplicate (to total nine experiments).</p>
</sec>
<sec id="Sec8">
<title>Statistics</title>
<p id="Par32">Statistical analyses were performed in the R statistical package (version 3.3.1). A Cox Proportional-Hazard regression function from the ‘survival’ package was used for the survival analysis. An initial univariate analysis was performed to determine any significant relation between each clinical factor in Table <xref ref-type="table" rid="Tab1">1</xref> and <italic>C. perfringens</italic> colonisation (defined as the earliest faecal sample where <italic>C. perfringens</italic> was isolated). Factors found to remain significant after a multiple hypothesis (Bonferroni) correction were entered into an iterative multivariate model, with factors found to have a <italic>p</italic> value of &gt; 0.1 being removed at each iterative step. Barnard’s test was performed to detect associations between antibiotic use and breast milk feeds and long-term carriage, and between toxin genes and NEC development. Growth rate comparisons were performed using generalized linear models and the ‘mass’ package using both the mean fold-change for each experimental triplicate and the mean absolute change in CFU. <italic>P</italic>-values shown were derived from the fold-change models, with similar results by either metric.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Demographics of infants included in the analysis (<italic>N</italic> = 333)</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Demographics</th><th>Number</th></tr></thead><tbody><tr><td colspan="2">Gestation</td></tr><tr><td> Mean gestation at birth in days (SD)</td><td>197 (16)</td></tr><tr><td> Median gestation at birth in days (IQR)</td><td>198 (27)</td></tr><tr><td colspan="2">Birth weight</td></tr><tr><td> Mean birth weight in g (SD)</td><td>1079.5 (340.8)</td></tr><tr><td> Median birth weight in g (IQR)</td><td>1025 (525)</td></tr><tr><td colspan="2">Gender</td></tr><tr><td> Female (%)</td><td>155 (46.5%)</td></tr><tr><td> Male (%)</td><td>178 (54.5%)</td></tr><tr><td colspan="2">Ethnicity</td></tr><tr><td> White (%)</td><td>130 (39.0%)</td></tr><tr><td> Mixed (%)</td><td>44 (13.2%)</td></tr><tr><td> Asian (%)</td><td>58 (17.4%)</td></tr><tr><td> Black (%)</td><td>74 (22.2%)</td></tr><tr><td> Unknown (%)</td><td>12 (3.6%)</td></tr><tr><td> Other (%)</td><td>15 (4.5%)</td></tr><tr><td colspan="2">Mode of delivery</td></tr><tr><td> Vaginal delivery (%)</td><td>137 (41.1%)</td></tr><tr><td> C-section (%)</td><td>196 (58.9%)</td></tr><tr><td colspan="2">Ventilation</td></tr><tr><td> Mean number of days requiring mechanical ventilation prior to CPC or LS (SD)</td><td>3.1 (8.2)</td></tr><tr><td> Median number of days requiring mechanical ventilation prior to CPC or LS (IQR)</td><td>1 (2)</td></tr><tr><td> Mean number of days CPAP (air) prior to CPC or LS (SD)</td><td>7.0 (8.7)</td></tr><tr><td> Median number of days CPAP (air) prior to CPC or LS (IQR)</td><td>4 (10)</td></tr><tr><td> Mean number of days CPAP (oxygen) prior to CPC or LS (SD)</td><td>9.3 (14.8)</td></tr><tr><td> Median number of days CPAP (oxygen) prior to CPC or LS (IQR)</td><td>2 (12)</td></tr><tr><td colspan="2">Feeding</td></tr><tr><td> Mean number of days of donor breast milk prior to CPC or LS (SD)</td><td>8.3 (8.9)</td></tr><tr><td> Median number of days of donor breast milk prior to CPC or LS (IQR)</td><td>6 (8)</td></tr><tr><td> Mean number of days of maternal breast milk prior to CPC or LS (SD)</td><td>23.0 (22.2)</td></tr><tr><td> Median number of days of maternal breast milk prior to CPC or LS (IQR)</td><td>17 (25)</td></tr><tr><td> Mean number of days of formula prior to CPC or LS (SD)</td><td>3.3 (9.0)</td></tr><tr><td> Median number of days of formula prior to CPC or LS (IQR)</td><td>0 (2)</td></tr><tr><td> Mean number of days of breast feeding prior to CPC or LS (SD)</td><td>3.4 (7.4)</td></tr><tr><td> Median number of days of breast feeding prior to CPC or LS (IQR)</td><td>0 (3)</td></tr><tr><td colspan="2">Antibiotic use</td></tr><tr><td> Mean number of days of antibiotic use at birth (SD)</td><td>2.4 (2.1)</td></tr><tr><td> Median number of days of antibiotic use at birth (IQR)</td><td>2 (2)</td></tr><tr><td> Mean number of days of antibiotic use prior to CPC or LS (SD)</td><td>5.1 (7.4)</td></tr><tr><td> Median number of days of antibiotic use prior to CPC or LS (IQR)</td><td>3 (4)</td></tr><tr><td colspan="2"><italic>C. perfringens</italic> colonisation</td></tr><tr><td> Number colonised with <italic>C. perfringens</italic> (%)</td><td>98 (29.4%)</td></tr><tr><td> Mean number of days prior to CPC (SD)</td><td>27.1 (23.3)</td></tr><tr><td> Median number of days prior to CPC (IQR)</td><td>21 (26)</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: <italic>CPC</italic> C<italic>. perfringens</italic> colonisation, <italic>LS</italic> Last sample, <italic>CPAP</italic>, Continuous positive airway pressure, <italic>SD</italic> Standard deviation, <italic>IQR</italic> Interquartile range</p></table-wrap-foot></table-wrap></p>
</sec>
</sec>
<sec id="Sec9">
<title>Results</title>
<sec id="Sec10">
<title><italic>C. perfringens</italic> incidence and clinical factors associated with its colonisation</title>
<p id="Par33">Faecal samples and complete clinical notes were available for 333 infants. The demographics of these babies are shown in Table <xref ref-type="table" rid="Tab1">1</xref>. <italic>C. perfringens</italic> was isolated in faecal samples from 98 of the infants (29.4%).</p>
<p id="Par34">Colonisation data were used to predict the risk of colonisation of the infant gut by <italic>C. perfringens</italic> over time through a survival analysis (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). By the day of life of the median stay on the neonatal unit for the cohort (29 days), a predicted 36% of infants would be colonised (95% confidence band 25, 43%).
<fig id="Fig1"><label>Fig. 1</label><caption><p>Kaplan-Meier plot of probability of colonisation by <italic>C.</italic>
<italic>perfringens</italic> over time. Data from our cohort of 333 infants. Dashed lines indicate the Hall-Wellner 95% confidence bands</p></caption><graphic id="MO1" xlink:href="12887_2020_1976_Fig1_HTML"></graphic></fig></p>
<p id="Par35">We next repeated the survival analysis with the aim of determining clinical variables (shown in Table <xref ref-type="table" rid="Tab1">1</xref>) that were associated with <italic>C. perfringens</italic> colonisation. A series of univariate models were created and significantly associated variables (after multiple hypothesis correction) are shown in Table <xref ref-type="table" rid="Tab2">2</xref>.
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Results of the univariate survival analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Variable</th><th colspan="5">Quartiles</th><th rowspan="2">Corrected<break></break><italic>P</italic> value</th><th rowspan="2">Coefficient</th><th rowspan="2">Exponentiated<break></break>Coefficient (95% CI)</th><th rowspan="2">Risk change for 75%<break></break>Quartile</th></tr><tr><th>0%</th><th>25%</th><th>50%</th><th>75%</th><th>100%</th></tr></thead><tbody><tr><td>Gestation (days)</td><td>161</td><td>184</td><td>198</td><td>211</td><td>223</td><td>0.002</td><td>0.026</td><td>1.026 (1.013–1.040)</td><td>3.688</td></tr><tr><td>Birth weight (g)</td><td>500</td><td>800</td><td>1025</td><td>1325</td><td>1890</td><td>&lt; 0.001</td><td>0.001</td><td>1.001 (1.001–1.002)</td><td>2.788</td></tr><tr><td>Days of mechanical ventilation</td><td>0</td><td>0</td><td>1</td><td>2</td><td>84</td><td>0.021</td><td>−0.076</td><td>0.927 (0.885–0.971)</td><td>0.860</td></tr><tr><td>Days of CPAP oxygen</td><td>0</td><td>0</td><td>2</td><td>12</td><td>80</td><td>&lt; 0.001</td><td>−0.039</td><td>0.962 (0.947–0.977)</td><td>0.626</td></tr><tr><td>Days of maternal milk feeds (non-breast)</td><td>0</td><td>6</td><td>14</td><td>29</td><td>114</td><td>&lt; 0.001</td><td>−0.057</td><td>0.945 (0.930–0.959)</td><td>0.192</td></tr><tr><td>Days of breast feeds</td><td>0</td><td>0</td><td>0</td><td>3</td><td>48</td><td>0.001</td><td>−0.073</td><td>0.929 (0.896–0.964)</td><td>0.802</td></tr><tr><td>Days of antibiotic use</td><td>0</td><td>2</td><td>3</td><td>6</td><td>79</td><td>&lt; 0.001</td><td>−0.116</td><td>0.89 (0.848–0.934)</td><td>0.497</td></tr></tbody></table></table-wrap></p>
<p id="Par36">For each significant factor, values are provided at each of its quartiles to illustrate the spread of data. The exponentiated coefficients provide the change in risk of colonisation per unit of each factor. Risk change indicates the relative change in risk of colonisation between the minimum value (0%) and the 75% quartile for a given clinical factor. Abbreviations: CI, confidence interval.</p>
<p id="Par37">Given the potential for correlation between these variables, a multivariate survival analysis was used to identify a minimal set of clinical factors to best predict colonisation. Four factors were found to remain significant in this model, with associations between increased probability of <italic>C. perfringens</italic> colonisation and fewer days of CPAP with supplemental oxygen (CPAP oxygen), fewer days of maternal milk feeds (via feeding tube), fewer days of breast feeding and fewer days of antibiotics over the course of the infant’s admission. The variation of colonisation probabilities when the infant cohort is divided into quartiles for each of these factors is shown in Fig. <xref ref-type="fig" rid="Fig2">2</xref>.
<fig id="Fig2"><label>Fig. 2</label><caption><p>Kaplan-Meier plots for each of the four significant factors in the multivariate model<bold>.</bold> X axis shows the infant day of life. Y axis shows the probability of colonisation for an infant when stratified according to quartiles (1st – 4th) of varying clinical factors: <bold>a</bold>) Days of CPAP oxygen, <bold>b</bold>) Days of maternal milk feeds (excluding breast feeds), <bold>c</bold>) Days of breast feeding and d) Days of antibiotics usage. Colour codes for the quartiles are shown in the top right of each subplot</p></caption><graphic id="MO2" xlink:href="12887_2020_1976_Fig2_HTML"></graphic></fig></p>
<p id="Par38">As the risk of colonisation for each infant is associated with the combined effects of each of these factors, we performed a multivariate analysis where each infant in the cohort was annotated either “low” (&lt;= median) or “high” (&gt;median) for each of the four factors. Multiple sets of analyses were run, illustrating the effects of higher than average measure of a single factor, or combinations thereof, on the probability of colonisation. The results are shown in Fig. <xref ref-type="fig" rid="Fig3">3</xref>.
<fig id="Fig3"><label>Fig. 3</label><caption><p>Kaplan-Meier plots showing combinations of the four significant factors when split into low or high categories. For ease of comparability, ‘All variables low’ (&lt;= median value for all four variables) and ‘All variables high’ (&gt;median value for all four variables) are shown on each chart</p></caption><graphic id="MO3" xlink:href="12887_2020_1976_Fig3_HTML"></graphic></fig></p>
<p id="Par39">The dominant variable of the four appeared to be feeds with breast milk, with increased feeds being associated with the greatest shift towards low probability of <italic>C. perfringens</italic> colonisation. We theorised two modes of action for this association, with breast milk acting either directly (inhibiting the growth of <italic>C. perfringens</italic>) or indirectly (promoting the growth of other components of the gastro-intestinal microbiota which outcompete <italic>C. perfringens</italic>). We explored these possibilities in culture experiments as follows.</p>
</sec>
<sec id="Sec11">
<title>Growth of <italic>C. perfringens</italic> in breast milk</title>
<p id="Par40">A <italic>C. perfringens</italic> isolate was grown in either nutrient rich medium (supplemented WCB broth) or breast milk, either as a monoculture or in co-culture with <italic>Bifidobacterium infantis</italic> which was chosen to represent a typical competing gut species, one that thrives on breast milk oligosaccharides [<xref ref-type="bibr" rid="CR23">23</xref>–<xref ref-type="bibr" rid="CR25">25</xref>]. Both species grew in each substrate and under both culture conditions, and each grew significantly better in rich medium under monoculture than in breast milk (<italic>B. infantis</italic>, <italic>p</italic> = 0.008, <italic>C. perfringens</italic>, <italic>p</italic> &lt; 0.0001). There was no significant difference in growth between the two species in the rich media when comparing the fold change between inoculation and the 20-h timepoint. However, in breast milk <italic>C. perfringens</italic> grew at a significantly lower rate than <italic>B. infantis</italic> in monoculture (<italic>p</italic> = 0.003) and co-culture (<italic>p</italic> = 0.0001). <italic>B. Infantis</italic> growth in breast milk was unaffected by mono- or co-culture, whilst growth of <italic>C. perfringens</italic> varied greatly but without significant association to breast milk type or mono- or co-culture (Fig. <xref ref-type="fig" rid="Fig4">4</xref>).
<fig id="Fig4"><label>Fig. 4</label><caption><p><italic>C. perfringens</italic> and <italic>B. infantis</italic> growth in rich media and breast milk. Each bacterium was grown in each medium separately (monoculture) or together (co-culture). Experiments were performed in triplicate with three technical replicates (all replicas shown). BM = Breast milk, with three different donations being used in the experiments (<bold>a</bold>, <bold>b</bold> and <bold>c</bold>)</p></caption><graphic id="MO4" xlink:href="12887_2020_1976_Fig4_HTML"></graphic></fig></p>
</sec>
<sec id="Sec12">
<title>Longitudinal carriage of <italic>C. perfringens</italic></title>
<p id="Par41">We sought to establish whether mother’s milk feeds or antibiotic treatments after the initial colonisation affected carriage of <italic>C. perfringens</italic>. 68 infants had at least one additional sample available after <italic>C. perfringens</italic> was first identified. Of these infants, 28% (<italic>n</italic> = 19) yielded no further isolates. For 31% of infants (<italic>n</italic> = 21), all subsequent samples were positive, while the remaining 41% of infants (<italic>n</italic> = 28) tested positive in at least half of their additional samples. We recorded whether the infants recevied maternal milk feeds, CPAP oxygen or antibiotic treatment in the week after their initial colonisation, and found none of the factors to be significantly asscoated with multiple isolation events compared to a single isolation (<italic>p</italic> = 0.75, 0.88 and 0.80 respectively).</p>
</sec>
<sec id="Sec13">
<title>Toxic potential of <italic>C. perfringens</italic> isolates</title>
<p id="Par42">The harmful effects of <italic>C. perfringens</italic> arise in large part through the production of toxins. Of particular interest in the neonatal field is the potential for <italic>C. perfringens</italic> toxin to play a part in the pathogenesis of NEC [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. We surveyed the <italic>C. perfringens</italic> isolates derived from our cohort for the presence of toxin genes through targeted PCR and found that a range of toxin genes were present. The presence of toxin genes in <italic>C. perfringens</italic> isolates during any point in their admission was scored for each neonate, allowing comparison of the toxic potential of the isolates prior to either discharge from the neonatal intensive care unit (“Control infants”) or NEC incidence (“NEC Infants”) (see Fig. <xref ref-type="fig" rid="Fig5">5</xref>).
<fig id="Fig5"><label>Fig. 5</label><caption><p><italic>C. perfringens</italic> toxin genes found in infants that developed NEC compared to control infants. Percentages were calculated out of the total number of control infants (<italic>n</italic> = 91) and infants that developed NEC Bell stage 2 (confirmed) or 3 (severe) (<italic>n</italic> = 5). Two infants who developed NEC Bell stage 1 (suspected) could not be categorised as cases or controls so were not included. A toxin gene was scored as present if it was found in any <italic>C. perfringens</italic> isolate found in an infant’s faecal samples during the course of either their whole time on the neonatal unit or up to the last sample prior to NEC development. The table shows the counts within the two groups and the relative percentages for toxin occurrence</p></caption><graphic id="MO5" xlink:href="12887_2020_1976_Fig5_HTML"></graphic></fig></p>
<p id="Par43">Statistical analyses (Barnard’s test and survival analysis) found no significant associations between the presence of toxin genes and the development of NEC. Given the infant numbers available in our cohort, Barnard’s test would detect a proportional increase of 0.19 or greater in the occurrence of toxin in infants developing NEC compared to controls with 95% confidence (assuming a one-sided test and 80% power). These results therefore do not support the hypothesis of NEC being associated with the prevalence of a particular toxin gene across our infant cohort. Overall, the most prevalent toxin genes in our neonatal <italic>C. perfringens</italic> isolates were <italic>cpa</italic>, <italic>pfoA</italic>, <italic>colA</italic> and <italic>cpb2</italic>, which were found in 100, 64, 99 and 50% of isolates respectively.</p>
</sec>
</sec>
<sec id="Sec14">
<title>Discussion</title>
<p id="Par44">We have found that just under a third of infants (29.4%) in our premature neonatal cohort were colonised with <italic>C. perfringens</italic> in their gut at some time during their stay in the neonatal intensive care unit (NICU), with duration of maternal milk feeds, antibiotic therapy, and continuous positive airway pressure with supplemental oxygen (CPAP oxygen) treatment exerting the strongest influence over probability of carriage. Our reported risk of colonisation with <italic>C. perfringens</italic> over time (approximately 25% at 3 weeks and 44% at 3 weeks) is very similar to findings in some other culture-dependent studies (35% at 3 weeks of life [<xref ref-type="bibr" rid="CR14">14</xref>], 46.1% at 7 weeks of life [<xref ref-type="bibr" rid="CR16">16</xref>]), although we are aware of one report of higher rates early in life (56.5% at 1 week of life [<xref ref-type="bibr" rid="CR26">26</xref>]).</p>
<p id="Par45">We have found a significant inverse association between both duration of maternal milk feeds and breast feeding and probability of <italic>C. perfringens</italic> colonisation. This is in line with studies of term infants, which have reported that formula-fed infants have higher gut Clostridia counts compared to those who were breast-fed [<xref ref-type="bibr" rid="CR27">27</xref>–<xref ref-type="bibr" rid="CR29">29</xref>]. Bioactive constituents (immunoglobulins, lysozyme, lactoferrin, antimicrobial peptides, oligosaccharides) and commensal microbes in breast milk [<xref ref-type="bibr" rid="CR30">30</xref>] actively protect against pathogen colonisation and invasion in the neonatal gut. An important mechanism of action is efficient metabolism of human milk oligosaccharides (HMOs) and subsequent acid production, for which <italic>B. infantis</italic> is especially adapted [<xref ref-type="bibr" rid="CR23">23</xref>]. Many other gut commensal species, including <italic>Clostridium</italic> species [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR31">31</xref>], cannot metabolise HMOs. Our growth experiments have shown that <italic>B. infantis</italic> significantly outperforms <italic>C. perfringens</italic> when grown in monoculture (<italic>p</italic> = 0.003) and co-culture (<italic>p</italic> = 0.0001) in breast milk. When the two species were cultured together, <italic>C. perfringens</italic> counts were not significantly reduced in the presence of <italic>B. infantis</italic> (<italic>p</italic> = 0.1083) hence we saw no evidence of direct inhibitory action. This comparison could be further confounded by a range of other factors; potential competition by low abundance organisms derived from the breast milk (predominantly Staphylococci), the impact of <italic>C. perfringen</italic> toxins on the growth of Bifidobacteria and the effect of potential oxygen exposure which would impact <italic>C. perfringens</italic> more strongly than <italic>Bifidobacterium</italic> [<xref ref-type="bibr" rid="CR32">32</xref>]. Direct inhibition by specific <italic>Bifidobacterium</italic> species has however been previously reported for growth of enteric pathogens (including <italic>C. perfringens</italic>) [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>] in vitro; for growth of NEC-associated clostridia in a quail model [<xref ref-type="bibr" rid="CR35">35</xref>]; and for clostridial growth in mouse models [<xref ref-type="bibr" rid="CR36">36</xref>]. It has recently been reported that term infants who are carriers of <italic>C. perfringens</italic> have consistently lower levels of Bifidobacteria in their gut compared to non-carriers [<xref ref-type="bibr" rid="CR37">37</xref>].</p>
<p id="Par46">Interestingly, the impact of breast milk on <italic>C. perfringens</italic> carriage we report was only found for infants fed their own mother’s milk (breast-fed or expressed into bottles), and not for those fed donor milk. In a recent systematic review [<xref ref-type="bibr" rid="CR38">38</xref>], heat-treating donor milk to meet safety standards (normally by Holder pasteurization - 62.5 °C for 30 min, [<xref ref-type="bibr" rid="CR21">21</xref>]), was shown consistently to reduce the level and/or activity of milk proteins including immunoglobulins, lactoferrin and enzymes, but had no effect on the lipid or saccharide content of milk. This suggests that donor milk may be inferior to maternal milk in an immunological capacity only, retaining qualities sufficient to influence <italic>C. perfringens</italic> colonisation patterns in some contexts. It has recently been demonstrated that neonatal mice can be protected from enteric infection by antibodies delivered through breast milk [<xref ref-type="bibr" rid="CR39">39</xref>]. The absence of competing milk commensals in donor milk may perhaps further explain why in our study it failed to influence <italic>C. perfringens</italic> carriage in the way that maternal milk did.</p>
<p id="Par47">Our results indicate that prolonged treatment with antibiotics or CPAP oxygen creates a hostile environment for <italic>C. perfringens</italic> in the preterm gut, reducing probability of carriage. <italic>C. perfringens</italic> may be particularly impacted by antibiotics due a rarity of multiple drug resistance genes [<xref ref-type="bibr" rid="CR40">40</xref>] compared to other members of the neonatal gut microbiota [<xref ref-type="bibr" rid="CR41">41</xref>]. A reduction in the abundance of <italic>C. perfringens</italic> in the preterm infant gut with antibiotic exposure has been observed in another cohort, although not reduced prevalence [<xref ref-type="bibr" rid="CR16">16</xref>]. While antibiotic prophylaxis is routine in preterm neonatal care, it has been shown to significantly alter the gut microbiota in preterm infants [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>] and to be associated with adverse health outcomes including NEC, sepsis and death [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]; the benefits of avoiding putative <italic>C. perfringens</italic>-induced pathologies such as NEC must be weighed against the risks of inducing gut dysbiosis when considering antibiotic regimes.</p>
<p id="Par48">Similar to Ferraris et al., [<xref ref-type="bibr" rid="CR16">16</xref>] we found that delivery mode had no effect on <italic>C. perfringens</italic> colonisation rates in our preterm neonatal cohort, in contrast to term infants [<xref ref-type="bibr" rid="CR46">46</xref>–<xref ref-type="bibr" rid="CR48">48</xref>].</p>
<p id="Par49">Our analysis of the longitudinal carriage of <italic>C. perfringens</italic> found no association between maternal milk feeds, CPAP oxygen or antibiotic treatment in the week after the initial isolation <italic>of C. perfringens</italic> and continued carriage (defined as at least half of subsequent samples testing positive). Our study may however be underpowered to conclude whether these factors truly influence long term carriage as there was limited time for observation between colonisation and the infants being discharged from the NICU.</p>
<p id="Par50">Our toxin typing results in a limited number of <italic>C. perfringens</italic>-associated NEC cases did not identify a specific toxin-mediated pathology. They have however provided evidence of a high occurrence of multi-toxigenic <italic>C. perfringens</italic> strains in the premature neonatal gut. The three most prevalent toxin genes in our neonatal <italic>C. perfringens</italic> isolates (<italic>cpa</italic>, <italic>pfoA</italic> and <italic>colA</italic>) can all be located to the same extracellular toxin gene cluster within a 250 kb region on the chromosome [<xref ref-type="bibr" rid="CR49">49</xref>]. Of note was the presence of the plasmid-encoded <italic>beta2</italic> toxin gene, which was found in50% of <italic>C. perfringens</italic>-positive infants. Although not fully elucidated, this toxin is strongly associated with porcine necrotic enteritis and is cytotoxic for human colorectal epithelial (CaCo-2) cells [<xref ref-type="bibr" rid="CR50">50</xref>]. Carriage of toxin genes, including <italic>beta2,</italic> is however observed in healthy human populations [<xref ref-type="bibr" rid="CR51">51</xref>], hence the toxic phenotype is likely highly situational.</p>
<p id="Par51">We detected other plasmid-encoded toxin genes in our neonatal isolates that have previously almost exclusively been detected in <italic>C. perfringens</italic> isolates from non-human species or cases of specific diseases: for example, the <italic>netB</italic> gene and necrotic enteritis in poultry, and <italic>becAB</italic> genes and food poisoning in Japan. The most notable example of this however, is the presence of the beta toxin gene (denoting type C <italic>C. perfringens</italic> when found with the alpha toxin and no other major toxin) in 17 infants. Type C <italic>C. perfringens</italic> in humans is normally only isolated in cases of necrotic enteritis (Pigbel) or from healthy humans in endemic areas. We hypothesise that there is a low level circulation of “aberrant” toxin genes in the neonatal population, presumably acquired from the mother at birth, and detectable in this study due to large sample sizes (273 isolates screened). It is important to consider however, the high level of discordance between genotype and phenotype for many of the <italic>C. perfringens</italic> toxins.</p>
</sec>
<sec id="Sec15">
<title>Conclusions</title>
<p id="Par52">We sought to understand the <italic>C. perfringens</italic> colonisation dynamics in a cohort of infants at high risk of mortality and morbidity from clostridia GI-induced pathologies. We used a traditional culture method combined with PCR to demonstrate that toxigenic <italic>C. perfringens</italic> is part of the normal gut microbiota in preterm neonates and report that approximately 30% are colonised before they leave the NICU. We have identified perinatal factors that are able to significantly affect the probability of <italic>C. perfringens</italic> carriage: increased duration of maternal milk feeds, increased duration of CPAP oxygen treatment, and increased duration of antibiotic treatment, which correlated with protection <italic>from C. perfringens</italic> colonisation. We demonstrated an inhibitory effect of breast milk on the growth of <italic>C. perfringens</italic> in vitro and reaffirm the importance of maternal milk feeding in preterm neonatal care.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary information</title>
<sec id="Sec16">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12887_2020_1976_MOESM1_ESM.docx"><caption><p><bold>Additional file 1. </bold><italic>C. perfringens</italic> toxin genes screened for in this study.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="12887_2020_1976_MOESM2_ESM.docx"><caption><p><bold>Additional file 2.</bold> PCR methods for toxin gene detection.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="12887_2020_1976_MOESM3_ESM.xlsx"><caption><p><bold>Additional file 3.</bold> Organisms grown in breast milk screening</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>BHI</term>
<def>
<p id="Par6">Brain heart infusion</p>
</def>
</def-item>
<def-item>
<term>BSM</term>
<def>
<p id="Par7">Bifidus selective medium</p>
</def>
</def-item>
<def-item>
<term>CFU</term>
<def>
<p id="Par8">Colony forming units</p>
</def>
</def-item>
<def-item>
<term>CI</term>
<def>
<p id="Par9">Confidence interval</p>
</def>
</def-item>
<def-item>
<term>CPAP</term>
<def>
<p id="Par10">Continuous positive airway pressure</p>
</def>
</def-item>
<def-item>
<term>CPC</term>
<def>
<p id="Par11"><italic>C. perfringens</italic> colonisation</p>
</def>
</def-item>
<def-item>
<term>CPE</term>
<def>
<p id="Par12"><italic>C. perfringens</italic> enterotoxin</p>
</def>
</def-item>
<def-item>
<term>HMO</term>
<def>
<p id="Par13">Human milk oligosaccharides</p>
</def>
</def-item>
<def-item>
<term>IQR</term>
<def>
<p id="Par14">Interquartile range</p>
</def>
</def-item>
<def-item>
<term>LS</term>
<def>
<p id="Par15">Last sample</p>
</def>
</def-item>
<def-item>
<term>MALDI-TOF</term>
<def>
<p id="Par16">Matrix-assisted laser desorption/ ionization–time of flight</p>
</def>
</def-item>
<def-item>
<term>NEC</term>
<def>
<p id="Par17">Necrotising enterocolitis</p>
</def>
</def-item>
<def-item>
<term>NICU</term>
<def>
<p id="Par18">Neonatal intensive care unit</p>
</def>
</def-item>
<def-item>
<term>PCR</term>
<def>
<p id="Par19">Polymerase chain reaction</p>
</def>
</def-item>
<def-item>
<term>SD</term>
<def>
<p id="Par20">Standard deviation</p>
</def>
</def-item>
<def-item>
<term>TSC</term>
<def>
<p id="Par21">Tryptose sulphite cycloserine</p>
</def>
</def-item>
<def-item>
<term>WCB</term>
<def>
<p id="Par22">Wilkins-chalgren broth</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Publisher’s Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
<fn>
<p>Alexander G. Shaw and Emma Cornwell contributed equally to this work.</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s12887-020-1976-7.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We thank the microbiology laboratory at Charing Cross Hospital, Imperial College Healthcare NHS Trust London for use of the MALDI-TOF facilities. We thank the participants and their families for their contribution to the study.</p>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>AGS contributed to the manuscript, designed and conducted culture-based experimental work and performed the statistical analyses. EC contributed to the manuscript, designed the competition experiments and conducted the culture-based experimental work. KS contributed to the manuscript and the culture-based experimental work. HS and HT conducted the culture-based experimental work and assembled cohort data. JCSB contributed to the manuscript and designed and conducted the toxin PCR experiments. RAB and JSK contributed to the experimental design. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="funding-information">
<title>Funding</title>
<p>This work was supported by funding from the Winnicott Foundation; Micropathology Ltd.; Innovate UK; and the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial Healthcare NHS Trust and Imperial College London. KS was funded during this work by an NIHR Doctoral Research Fellowship [NIHR-DRF-2011-04-128]. This article presents independent research funded by the NIHR. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health or other funders. Funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.</p>
</notes>
<notes notes-type="data-availability">
<title>Availability of data and materials</title>
<p>Not applicable.</p>
</notes>
<notes>
<title>Ethics approval and consent to participate</title>
<p id="Par53">The study “Defining the Intestinal Microbiota in Premature Infants” (<ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov">ClinicalTrials.gov</ext-link> identifier NCT01102738) was approved by West London Research Ethics Committee Two (National Health Service Health Research Authority), United Kingdom (reference number 10/H0711/39). Parents gave written informed consent for their infant to participate in the study.</p>
</notes>
<notes>
<title>Consent for publication</title>
<p id="Par54">Not applicable.</p>
</notes>
<notes notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par55">The authors declare that they have no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stevens</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Aldape</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Bryant</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>Life-threatening clostridial infections</article-title>
<source/>Anaerobe
          <year>2012</year>
<volume>18</volume>
<issue>2</issue>
<fpage>254</fpage>
<lpage>259</lpage>
<pub-id pub-id-type="doi">10.1016/j.anaerobe.2011.11.001</pub-id>
<pub-id pub-id-type="pmid">22120198</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<mixed-citation publication-type="other">Centers for Disease Control and Prevention. Food Safety Homepage, Foodborne Illness A-Z, <italic>Clostridium perfringens</italic>. <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/foodsafety/diseases/clostridium-perfringens.html%202015">http://www.cdc.gov/foodsafety/diseases/clostridium-perfringens.html 2015</ext-link>. Accessed Nov 2017.</mixed-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>WA</given-names>
</name>
</person-group>
<article-title>Necrotizing enterocolitis</article-title>
<source/>N Engl J Med
          <year>2011</year>
<volume>364</volume>
<issue>3</issue>
<fpage>255</fpage>
<lpage>264</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMra1005408</pub-id>
<pub-id pub-id-type="pmid">21247316</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blakey</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Lubitz</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>NT</given-names>
</name>
<name>
<surname>Gillam</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>GL</given-names>
</name>
</person-group>
<article-title>Enteric colonization in sporadic neonatal necrotizing enterocolitis</article-title>
<source/>J Pediatr Gastroenterol Nutr
          <year>1985</year>
<volume>4</volume>
<issue>4</issue>
<fpage>591</fpage>
<lpage>595</lpage>
<pub-id pub-id-type="doi">10.1097/00005176-198508000-00017</pub-id>
<pub-id pub-id-type="pmid">2863341</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dittmar</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Beyer</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Schäfer</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Schoepe</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Necrotizing enterocolitis of the neonate with Clostridium perfringens: diagnosis, clinical course, and role of alpha toxin</article-title>
<source/>Eur J Pediatr
          <year>2008</year>
<volume>167</volume>
<issue>8</issue>
<fpage>891</fpage>
<lpage>895</lpage>
<pub-id pub-id-type="doi">10.1007/s00431-007-0614-9</pub-id>
<pub-id pub-id-type="pmid">17952466</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heida</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>van Zoonen</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Hulscher</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>te Kiefte</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Wessels</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kooi</surname>
<given-names>EM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A necrotizing Enterocolitis-associated gut microbiota is present in the meconium: results of a prospective study</article-title>
<source/>Clin Infec Dis : Official Publication Infec Dis Soc Am
          <year>2016</year>
<volume>62</volume>
<issue>7</issue>
<fpage>863</fpage>
<lpage>870</lpage>
<pub-id pub-id-type="doi">10.1093/cid/ciw016</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sim</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Randell</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>McClure</surname>
<given-names>ZE</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M-S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dysbiosis anticipating necrotizing Enterocolitis in very premature infants</article-title>
<source/>Clin Infec Dis: Official Publication Infec Dis Soc Am
          <year>2015</year>
<volume>60</volume>
<issue>3</issue>
<fpage>389</fpage>
<lpage>397</lpage>
<pub-id pub-id-type="doi">10.1093/cid/ciu822</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warner</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Deych</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hall-Moore</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Weinstock</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Sodergren</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study</article-title>
<source/>Lancet
          <year>2016</year>
<volume>387</volume>
<issue>10031</issue>
<fpage>1928</fpage>
<lpage>1936</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(16)00081-7</pub-id>
<pub-id pub-id-type="pmid">26969089</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dobbler</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Procianoy</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Mai</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Silveira</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Corso</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Rojas</surname>
<given-names>BS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Low microbial diversity and abnormal microbial succession is associated with necrotizing Enterocolitis in preterm infants</article-title>
<source/>Front Microbiol
          <year>2017</year>
<volume>8</volume>
<fpage>2243</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2017.02243</pub-id>
<pub-id pub-id-type="pmid">29187842</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Penders</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Thijs</surname>
<given-names>C</given-names>
</name>
<name>
<surname>van den Brandt</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Kummeling</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Snijders</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Stelma</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota composition and development of atopic manifestations in infancy: the KOALA birth cohort study</article-title>
<source/>Gut
          <year>2007</year>
<volume>56</volume>
<fpage>661</fpage>
<lpage>667</lpage>
<pub-id pub-id-type="doi">10.1136/gut.2006.100164</pub-id>
<pub-id pub-id-type="pmid">17047098</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Björkstén</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sepp</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Julge</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Voor</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mikelsaar</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Allergy development and the intestinal microflora during the first year of life</article-title>
<source/>J Allergy Clin Immunol
          <year>2001</year>
<volume>108</volume>
<issue>4</issue>
<fpage>516</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="doi">10.1067/mai.2001.118130</pub-id>
<pub-id pub-id-type="pmid">11590374</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martirosian</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ekiel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Aptekorz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wiechula</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kazek</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Jankowska-Steifer</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fecal lactoferrin and Clostridium spp. in stools of autistic children</article-title>
<source/>Anaerobe
          <year>2011</year>
<volume>17</volume>
<issue>1</issue>
<fpage>43</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1016/j.anaerobe.2010.12.003</pub-id>
<pub-id pub-id-type="pmid">21167951</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finegold</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Molitoris</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vaisanen</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Bolte</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gastrointestinal microflora studies in late-onset autism</article-title>
<source/>Clin Infect Dis
          <year>2002</year>
<volume>35</volume>
<issue>Suppl 1</issue>
<fpage>S6</fpage>
<lpage>s16</lpage>
<pub-id pub-id-type="doi">10.1086/341914</pub-id>
<pub-id pub-id-type="pmid">12173102</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blakey</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Lubitz</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>NT</given-names>
</name>
<name>
<surname>Gillam</surname>
<given-names>GL</given-names>
</name>
</person-group>
<article-title>Development of gut colonisation in pre-term neonates</article-title>
<source/>J Med Microbiol
          <year>1982</year>
<volume>15</volume>
<issue>4</issue>
<fpage>519</fpage>
<lpage>529</lpage>
<pub-id pub-id-type="doi">10.1099/00222615-15-4-519</pub-id>
<pub-id pub-id-type="pmid">6816935</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arboleya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Binetti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Salazar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fernández</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Solís</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hernández-Barranco</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Establishment and development of intestinal microbiota in preterm neonates</article-title>
<source/>FEMS Microbiol Ecol
          <year>2012</year>
<volume>79</volume>
<issue>3</issue>
<fpage>763</fpage>
<lpage>772</lpage>
<pub-id pub-id-type="doi">10.1111/j.1574-6941.2011.01261.x</pub-id>
<pub-id pub-id-type="pmid">22126419</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferraris</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Butel</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Campeotto</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Vodovar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rozé</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Aires</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Clostridia in premature Neonates' gut: incidence, antibiotic susceptibility, and perinatal determinants influencing colonization</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<issue>1</issue>
<fpage>e30594</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0030594</pub-id>
<pub-id pub-id-type="pmid">22291996</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<article-title>An update on the human and animal enteric pathogen Clostridium perfringens</article-title>
<source/>Emerg Microbes Infect
          <year>2018</year>
<volume>7</volume>
<issue>1</issue>
<fpage>141</fpage>
<pub-id pub-id-type="doi">10.1038/s41426-018-0144-8</pub-id>
<pub-id pub-id-type="pmid">30082713</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uzal</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Freedman</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Shrestha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Theoret</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Awad</surname>
<given-names>MM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease</article-title>
<source/>Future Microbiol
          <year>2014</year>
<volume>9</volume>
<issue>3</issue>
<fpage>361</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="doi">10.2217/fmb.13.168</pub-id>
<pub-id pub-id-type="pmid">24762309</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Asten</surname>
<given-names>AJAM</given-names>
</name>
<name>
<surname>van der Wiel</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Nikolaou</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Houwers</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Gröne</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>A multiplex PCR for toxin typing of Clostridium perfringens isolates</article-title>
<source/>Vet Microbiol
          <year>2009</year>
<volume>136</volume>
<issue>3</issue>
<fpage>411</fpage>
<lpage>412</lpage>
<pub-id pub-id-type="doi">10.1016/j.vetmic.2008.11.024</pub-id>
<pub-id pub-id-type="pmid">19157726</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<mixed-citation publication-type="other">Public Health England. UK standards for microbiology investigations: processing of faeces for <italic>Clostridium difficile</italic>.: Available at: <ext-link ext-link-type="uri" xlink:href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/343912/B_10i1.5.pdf">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/343912/B_10i1.5.pdf</ext-link>; 2014. Accessed Nov 2017.</mixed-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<mixed-citation publication-type="other">Excellence NIfCaH. Donor milk banks: service operation. In: NICE Guidance CgC, editor.: Available at <ext-link ext-link-type="uri" xlink:href="https://www.nice.org.uk/guidance/CG93/chapter/1-Guidance;">https://www.nice.org.uk/guidance/CG93/chapter/1-Guidance;</ext-link> 2010. Accessed Nov 2017.</mixed-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kotsanas</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Carson</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Awad</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Lyras</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rood</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Jenkin</surname>
<given-names>GA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Novel use of Tryptose sulfite Cycloserine egg yolk agar for isolation of Clostridium perfringens during an outbreak of necrotizing Enterocolitis in a neonatal unit</article-title>
<source/>J Clin Microbiol
          <year>2010</year>
<volume>48</volume>
<issue>11</issue>
<fpage>4263</fpage>
<lpage>4265</lpage>
<pub-id pub-id-type="doi">10.1128/JCM.01724-10</pub-id>
<pub-id pub-id-type="pmid">20826643</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sela</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Adeuya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Whitehead</surname>
<given-names>TR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2008</year>
<volume>105</volume>
<issue>48</issue>
<fpage>18964</fpage>
<lpage>18969</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0809584105</pub-id>
<pub-id pub-id-type="pmid">19033196</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marcobal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Barboza</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Froehlich</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Block</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>German</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Lebrilla</surname>
<given-names>CB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Consumption of human Milk oligosaccharides by gut-related microbes</article-title>
<source/>J Agric Food Chem
          <year>2010</year>
<volume>58</volume>
<issue>9</issue>
<fpage>5334</fpage>
<lpage>5340</lpage>
<pub-id pub-id-type="doi">10.1021/jf9044205</pub-id>
<pub-id pub-id-type="pmid">20394371</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rockova</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rada</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Marsik</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Vlkova</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bunesova</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Sklenar</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Growth of bifidobacteria and clostridia on human and cow milk saccharides</article-title>
<source/>Anaerobe
          <year>2011</year>
<volume>17</volume>
<issue>5</issue>
<fpage>223</fpage>
<lpage>225</lpage>
<pub-id pub-id-type="doi">10.1016/j.anaerobe.2011.07.009</pub-id>
<pub-id pub-id-type="pmid">21839845</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rotimi</surname>
<given-names>VO</given-names>
</name>
<name>
<surname>Olowe</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>The development of bacterial flora of premature neonates</article-title>
<source/>J Hyg
          <year>1985</year>
<volume>94</volume>
<issue>3</issue>
<fpage>309</fpage>
<lpage>318</lpage>
<pub-id pub-id-type="doi">10.1017/S0022172400061532</pub-id>
<pub-id pub-id-type="pmid">3891849</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stark</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life</article-title>
<source/>J Med Microbiol
          <year>1982</year>
<volume>15</volume>
<issue>2</issue>
<fpage>189</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1099/00222615-15-2-189</pub-id>
<pub-id pub-id-type="pmid">7143428</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benno</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sawada</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mitsuoka</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants</article-title>
<source/>Microbiol Immunol
          <year>1984</year>
<volume>28</volume>
<issue>9</issue>
<fpage>975</fpage>
<lpage>986</lpage>
<pub-id pub-id-type="doi">10.1111/j.1348-0421.1984.tb00754.x</pub-id>
<pub-id pub-id-type="pmid">6513816</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fallani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Amarri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Uusijarvi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Adam</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Khanna</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aguilera</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Determinants of the human infant intestinal microbiota after the introduction of first complementary foods in infant samples from five European centres</article-title>
<source/>Microbiology (Reading, England)
          <year>2011</year>
<volume>157</volume>
<issue>Pt 5</issue>
<fpage>1385</fpage>
<lpage>1392</lpage>
<pub-id pub-id-type="doi">10.1099/mic.0.042143-0</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fitzstevens</surname>
<given-names>John L.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>Kelsey C.</given-names>
</name>
<name>
<surname>Hagadorn</surname>
<given-names>James I.</given-names>
</name>
<name>
<surname>Caimano</surname>
<given-names>Melissa J.</given-names>
</name>
<name>
<surname>Matson</surname>
<given-names>Adam P.</given-names>
</name>
<name>
<surname>Brownell</surname>
<given-names>Elizabeth A.</given-names>
</name>
</person-group>
<article-title>Systematic Review of the Human Milk Microbiota</article-title>
<source/>Nutrition in Clinical Practice
          <year>2016</year>
<volume>32</volume>
<issue>3</issue>
<fpage>354</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="doi">10.1177/0884533616670150</pub-id>
<pub-id pub-id-type="pmid">27679525</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>ZT</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kling</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>McCoy</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Merighi</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota</article-title>
<source/>Glycobiology
          <year>2013</year>
<volume>23</volume>
<issue>2</issue>
<fpage>169</fpage>
<lpage>177</lpage>
<pub-id pub-id-type="doi">10.1093/glycob/cws138</pub-id>
<pub-id pub-id-type="pmid">23028202</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rolfe</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Hentges</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Barrett</surname>
<given-names>JT</given-names>
</name>
</person-group>
<article-title>Factors related to the oxygen tolerance of anaerobic bacteria</article-title>
<source/>Appl Environ Microbiol
          <year>1978</year>
<volume>36</volume>
<issue>2</issue>
<fpage>306</fpage>
<lpage>313</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.36.2.306-313.1978</pub-id>
<pub-id pub-id-type="pmid">697363</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hutt</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Shchepetova</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Loivukene</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kullisaar</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mikelsaar</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens</article-title>
<source/>J Appl Microbiol
          <year>2006</year>
<volume>100</volume>
<issue>6</issue>
<fpage>1324</fpage>
<lpage>1332</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2672.2006.02857.x</pub-id>
<pub-id pub-id-type="pmid">16696680</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Balciunas</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Converti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cotter</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>de Souza Oliveira</surname>
<given-names>RP</given-names>
</name>
</person-group>
<article-title>Bacteriocin production by Bifidobacterium spp</article-title>
<source/>Rev Biotechnol Adv
          <year>2013</year>
<volume>31</volume>
<issue>4</issue>
<fpage>482</fpage>
<lpage>488</lpage>
<pub-id pub-id-type="doi">10.1016/j.biotechadv.2013.01.010</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butel</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Roland</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hibert</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Popot</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Favre</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tessedre</surname>
<given-names>AC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clostridial pathogenicity in experimental necrotising enterocolitis in gnotobiotic quails and protective role of bifidobacteria</article-title>
<source/>J Med Microbiol
          <year>1998</year>
<volume>47</volume>
<issue>5</issue>
<fpage>391</fpage>
<lpage>399</lpage>
<pub-id pub-id-type="doi">10.1099/00222615-47-5-391</pub-id>
<pub-id pub-id-type="pmid">9879939</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukuda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Toh</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hase</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Oshima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nakanishi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yoshimura</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bifidobacteria can protect from enteropathogenic infection through production of acetate</article-title>
<source/>Nature.
          <year>2011</year>
<volume>469</volume>
<issue>7331</issue>
<fpage>543</fpage>
<lpage>547</lpage>
<pub-id pub-id-type="doi">10.1038/nature09646</pub-id>
<pub-id pub-id-type="pmid">21270894</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagpal</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tsuji</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nomoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kawashima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nagata</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut dysbiosis following C-section instigates higher colonisation of toxigenic Clostridium perfringens in infants</article-title>
<source/>Benefic Microbes
          <year>2017</year>
<volume>8</volume>
<issue>3</issue>
<fpage>353</fpage>
<lpage>365</lpage>
<pub-id pub-id-type="doi">10.3920/BM2016.0216</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peila</surname>
<given-names>Chiara</given-names>
</name>
<name>
<surname>Moro</surname>
<given-names>Guido</given-names>
</name>
<name>
<surname>Bertino</surname>
<given-names>Enrico</given-names>
</name>
<name>
<surname>Cavallarin</surname>
<given-names>Laura</given-names>
</name>
<name>
<surname>Giribaldi</surname>
<given-names>Marzia</given-names>
</name>
<name>
<surname>Giuliani</surname>
<given-names>Francesca</given-names>
</name>
<name>
<surname>Cresi</surname>
<given-names>Francesco</given-names>
</name>
<name>
<surname>Coscia</surname>
<given-names>Alessandra</given-names>
</name>
</person-group>
<article-title>The Effect of Holder Pasteurization on Nutrients and Biologically-Active Components in Donor Human Milk: A Review</article-title>
<source/>Nutrients
          <year>2016</year>
<volume>8</volume>
<issue>8</issue>
<fpage>477</fpage>
<pub-id pub-id-type="doi">10.3390/nu8080477</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Caro</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbiota-targeted maternal antibodies protect neonates from enteric infection</article-title>
<source/>Nature
          <year>2020</year>
<volume>577</volume>
<issue>7791</issue>
<fpage>543</fpage>
<lpage>548</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-019-1898-4</pub-id>
<pub-id pub-id-type="pmid">31915378</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Caim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pachori</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<article-title>Probing genomic aspects of the multi-host pathogen Clostridium perfringens reveals significant Pangenome diversity, and a diverse Array of virulence factors</article-title>
<source/>Front Microbiol
          <year>2017</year>
<volume>8</volume>
<fpage>2485</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2017.02485</pub-id>
<pub-id pub-id-type="pmid">29312194</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rose</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Sim</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wooldridge</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Gharbia</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Antibiotic resistance potential of the healthy preterm infant gut microbiome</article-title>
<source/>PeerJ
          <year>2017</year>
<volume>5</volume>
<fpage>e2928</fpage>
<pub-id pub-id-type="doi">10.7717/peerj.2928</pub-id>
<pub-id pub-id-type="pmid">28149696</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arboleya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sánchez</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Milani</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Duranti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Solís</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Fernández</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intestinal microbiota development in preterm neonates and effect of perinatal antibiotics</article-title>
<source/>J Pediatr
          <year>2015</year>
<volume>166</volume>
<issue>3</issue>
<fpage>538</fpage>
<lpage>544</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpeds.2014.09.041</pub-id>
<pub-id pub-id-type="pmid">25444008</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenwood</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Morrow</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Lagomarcino</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Altaye</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Taft</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter</article-title>
<source/>J Pediatr
          <year>2014</year>
<volume>165</volume>
<issue>1</issue>
<fpage>23</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpeds.2014.01.010</pub-id>
<pub-id pub-id-type="pmid">24529620</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuppala</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Meinzen-Derr</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Morrow</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Schibler</surname>
<given-names>KR</given-names>
</name>
</person-group>
<article-title>Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants</article-title>
<source/>J Pediatr
          <year>2011</year>
<volume>159</volume>
<issue>5</issue>
<fpage>720</fpage>
<lpage>725</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpeds.2011.05.033</pub-id>
<pub-id pub-id-type="pmid">21784435</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cotten</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Stoll</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>NI</given-names>
</name>
<name>
<surname>Sanchez</surname>
<given-names>PJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants</article-title>
<source/>Pediatrics.
          <year>2009</year>
<volume>123</volume>
<issue>1</issue>
<fpage>58</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2007-3423</pub-id>
<pub-id pub-id-type="pmid">19117861</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Penders</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Thijs</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vink</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Stelma</surname>
<given-names>FF</given-names>
</name>
<name>
<surname>Snijders</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kummeling</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Factors influencing the composition of the intestinal microbiota in early infancy</article-title>
<source/>Pediatrics
          <year>2006</year>
<volume>118</volume>
<issue>2</issue>
<fpage>511</fpage>
<lpage>521</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2005-2824</pub-id>
<pub-id pub-id-type="pmid">16882802</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gronlund</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Lehtonen</surname>
<given-names>OP</given-names>
</name>
<name>
<surname>Eerola</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kero</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery</article-title>
<source/>J Pediatr Gastroenterol Nutr
          <year>1999</year>
<volume>28</volume>
<issue>1</issue>
<fpage>19</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1097/00005176-199901000-00007</pub-id>
<pub-id pub-id-type="pmid">9890463</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biasucci</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rubini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Riboni</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Morelli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bessi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Retetangos</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Mode of delivery affects the bacterial community in the newborn gut</article-title>
<source/>Early Hum Dev
          <year>2010</year>
<volume>86</volume>
<issue>Suppl 1</issue>
<fpage>13</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1016/j.earlhumdev.2010.01.004</pub-id>
<pub-id pub-id-type="pmid">20133091</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katayama</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dupuy</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Garnier</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>ST</given-names>
</name>
</person-group>
<article-title>Rapid expansion of the physical and genetic map of the chromosome of Clostridium perfringens CPN50</article-title>
<source/>J Bacteriol
          <year>1995</year>
<volume>177</volume>
<issue>19</issue>
<fpage>5680</fpage>
<lpage>5685</lpage>
<pub-id pub-id-type="doi">10.1128/JB.177.19.5680-5685.1995</pub-id>
<pub-id pub-id-type="pmid">7559358</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fisher</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Miyamoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Akimoto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sarker</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>McClane</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Association of beta2 toxin production with Clostridium perfringens type a human gastrointestinal disease isolates carrying a plasmid enterotoxin gene</article-title>
<source/>Mol Microbiol
          <year>2005</year>
<volume>56</volume>
<issue>3</issue>
<fpage>747</fpage>
<lpage>762</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2958.2005.04573.x</pub-id>
<pub-id pub-id-type="pmid">15819629</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lakshminarayanan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Coakley</surname>
<given-names>M</given-names>
</name>
<name>
<surname>O'Sullivan</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Stanton</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pruteanu</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence and characterization of Clostridium perfringens from the faecal microbiota of elderly Irish subjects</article-title>
<source/>J Med Microbiol
          <year>2013</year>
<volume>62</volume>
<issue>Pt 3</issue>
<fpage>457</fpage>
<lpage>466</lpage>
<pub-id pub-id-type="doi">10.1099/jmm.0.052258-0</pub-id>
<pub-id pub-id-type="pmid">23222860</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>